Since 2020, aggregated from related topics
Immune checkpoint inhibitors are a type of cancer treatment that work by blocking certain proteins on immune cells, allowing the immune system to better attack cancer cells. These proteins, called checkpoint proteins, act as "brakes" on the immune system, preventing it from attacking healthy cells. By blocking these proteins, immune checkpoint inhibitors help the immune system recognize and attack cancer cells more effectively. This form of treatment has shown promise in treating various types of cancer, including melanoma, lung cancer, and bladder cancer. Immune checkpoint inhibitors have been hailed as a significant advancement in cancer treatment and have revolutionized the field of immuno-oncology.